For patients with primary pancreatic pseudocysts with elevated serum CEA and CA19-9 levels, we should not rule out pancreatic cancer, which may also be a manifestation of primary pancreatic SCC. This evidence concerns the gene CEACAM5 and familial pancreatic carcinoma.